The Montreal Cancer Institute is pleased to announce the appointment of Mr. Gerardo Ferbeyre as the head of the Cancer axis at the CRCHUM, effective May 1, 2024. In assuming this role, Mr. Ferbeyre will also serve as the Scientific Director of the Montreal Cancer Institute.

The community at the Montreal Cancer Institute wishes to express sincere gratitude to outgoing Scientific Director, Réjean Lapointe, for his dedication and excellence in his role. His remarkable contributions have greatly benefited the Institute, and we extend our best wishes to him for his future endeavors.

We are confident that Mr. Gerardo Ferbeyre, with his skills and commitment, will continue to enhance the scientific aspect of the Institute’s mission.

As a tenured professor in the Department of Biochemistry at the University of Montreal, Mr. Ferbeyre has been a regular researcher at the CRCHUM since June 2018, and previously served as co-director of the University Research Group on Medicines (GRUM) from 2012 to 2021. Since 2019, he has also been responsible for graduate studies within the Department of Biochemistry.

Mr. Gerardo Ferbeyre’s laboratory at the CRCHUM is renowned for its excellence in aging research and its impact in the field of cancer. With over thirty years of experience in academic research, Mr. Ferbeyre now aspires to actively contribute to the development of his axis, fostering collaboration with other axes at the CRCHUM.